News/ R&D Teva walks away from Mesoblast’s heart failure drug Richard Staines cardiology, heart, Mesoblast, R&D, stem cell, Teva 0 Comment Mesoblast to continue developing stem cell based therapy. Share X Teva walks away from Mesoblast’s heart failure drug https://pharmaphorum.com/news/teva-walks-away-mesoblasts-heart-failure-drug/